210 research outputs found
QRsens:dual-purpose quick response code with built-in colorimetric sensors
QRsens represents a family of Quick Response (QR) sensing codes for in-situ air analysis with a customized smartphone application to simultaneously read the QR code and the colorimetric sensors. Five colorimetric sensors (temperature, relative humidity (RH), and three gas sensors (CO₂, NH₃ and H₂S)) were designed with the aim of proposing two end-use applications for ambient analysis, i.e., enclosed spaces monitoring, and smart packaging. Both QR code and colorimetric sensing inks were deposited by standard screen printing on white paper. To ensure minimal ambient light dependence of QRsens during the real-time analysis, the smartphone application was programmed for an effective colour correction procedure based on black and white references for three standard illumination temperatures (3000, 4000 and 5000 K). Depending on the type of sensor being analysed, this integration achieved a reduction of ∼71 – 87% of QRsens's dependence on the light temperature. After the illumination colour correction, colorimetric gas sensors exhibited a detection range of 0.7–4.1%, 0.7–7.5 ppm, and 0.13–0.7 ppm for CO2, NH3 and H2S, respectively. In summary, the study presents an affordable built-in multi-sensing platform in the form of QRsens for in-situ monitoring with potential in different types of ambient air analysis applications
Financial cost of the admissions for simultaneous pancreas-kidney transplant in a Brazilian Hospital
Structural and spectroscopic investigation of the charge-ordered, short-range ordered, and disordered phases of the Co3O2BO3 ludwigite
Charge ordering is prone to occur in crystalline materials with mixed-valence ions. It is presumably accompanied by a structural phase transition, with possible exceptions in compounds that already present more than one inequivalent site for the mixed-valence ions in the charge-disordered phase. In this work, we investigate the representative case of the homometallic Co ludwigite Co2+2Co3+O2BO3 (Pbam space group) with four distinct Co crystallographic sites [M1–M4] surrounded by oxygen octahedra. The mixed-valent character of the Co ions up to at least T=873 K is verified through x-ray absorption near-edge structure (XANES) experiments. Single crystal x-ray diffraction (XRD) and neutron powder diffraction (NPD) confirm that the Co ions at the M4 site are much smaller than the others at low temperatures, consistent with a Co3+ oxidation state at M4 and Co2+ at the remaining sites. The size difference between the Co ions in the M4 and M2 sites is continuously reduced upon warming above ≈370 K, indicating a gradual charge redistribution within the M4−M2−M4 (424) ladder in the average structure. Minor structural anomalies with no space group modification are observed near 475 and 495 K, where sharp phase transitions were previously revealed by calorimetry and electrical resistivity data. An increasing structural disorder, beyond a conventional thermal effect, is noted above ≈370 K, manifested by an anomalous increment of XRD Debye-Waller factors and broadened vibrational modes observed by Raman scattering. The local Co-O distance distribution, revealed by Co K-edge extended x-ray absorption fine structure (EXAFS) data and analyzed with an evolutionary algorithm method, is similar to that inferred from the XRD crystal structure below ≈370 K. At higher temperatures, the local Co-O distance distribution remains similar to that found at low temperatures, at variance with the average crystal structure obtained with XRD. We conclude that the oxidation states Co2+ and Co3+ are instantaneously well defined in a local atomic level at all temperatures, however the thermal energy promotes local defects in the charge-ordered configuration of the 424 ladders upon warming. These defects coalesce into a phase-segregated state within a narrow temperature interval (475<T<495 K). Finally, a transition at ≈500 K revealed by differential scanning calorimetry (DSC) in the iron ludwigite Fe3O2BO3 is discussed
Cruise Summary Report - MEDWAVES survey. MEDiterranean out flow WAter and Vulnerable EcosystemS (MEDWAVES)
The MEDWAVES (MEDiterranean out flow WAter and Vulnerable EcosystemS) cruise targeted areas under the potential influence of the MOW within the Mediterranean and Atlantic realms. These include seamounts where Cold-water corals (CWCs) have been reported but that are still poorly known, and which may act as essential “stepping stones” connecting fauna of seamounts in the Mediterranean with those of the continental shelf of Portugal, the Azores and the Mid-Atlantic Ridge. During MEDWAVES sampling has been conducted in two of the case studies of ATLAS: Case study 7 (Gulf of Cádiz-Strait of Gibraltar-Alboran Sea) and Case study 8 (Azores).
The initially targeted areas in the Atlantic were: the Gazul Mud volcano, in the Gulf of Cádiz (GoC) area, included in the case study 7, and the Atlantic seamounts Ormonde (Portuguese shelf) and Formigas (by Azores), both part of the case study 8. In the Mediterranean the targeted areas were The Guadiaro submarine canyon and the Seco de los Olivos (also known as Chella Bank) seamount. Unfortunately it was not possible to sample in Guadiaro due to time constraints originated by adverse meteorological conditions which obligate us to reduce the time at sea focusing only in 4 of the 5 initially planned areas.
MEDWAVES was structured in two legs; the first leg took place from the 21st September (departure from Cádiz harbour in Spain) to the 13th October 2016 (arrival in Ponta Delgada, São Miguel, Azores, Portugal took place the 8th of October due to the meteorological conditions that obligated to conclude the first leg earlier as planned). during the Leg 1 sampling was carried out in Gazul, Ormonde and Formigas. The second leg started the 14th October (departure from Ponta Delgada) and finished the 26th October (arrival in Málaga harbour, Spain). MEDWAVES had a total of 30 effective sampling days, being 6 days not operative due to the adverse meteorological conditions experienced during the first leg which forced us to stay in Ponta Delgada from the 08th to the 13th October.
During MEDWAVES the daily routine followed a similar scheme, depending of course on the weather and sea conditions. The main activity during the day, starting early in the morning (around 08:00 AM, once the night activities were finished), was the ROV deployment. Generally a single ROV dive of around 8 hours was performed, however in several occasions two dives were carried out in the same day (see General station list, Appendix II). After the ROV (and sometimes between two dives) the Box Corer and/or Van Veen Grab and/or Multicore was deployed. After these activities, during the night CTD-Rosette deployments and MB was conducted. Accordingly to this schema the scientific personnel worked in the day or in the night watch.
A total of 215 sampling stations have been covered in MEDWAVES, using the following sampling gears: Multibeam echosounder, CTD-Rosette, LADCP, Box Corer, Van Veen Grab, Multicorer and a Remotely Operated Vehicle (ROV). Table 1 sumamrised the number of sampling stations conducted with each gear in each sampling zone. Additionally MB surveys have been conducted during the transits between area
Clinical Practice Guideline for the Diagnosis and Management of Adult Patients with Functional Chronic Constipation
Resumen
Objetivo: diseñar una guía de práctica clínica para orientar el diagnóstico, y establecer la clasificación y el
tratamiento farmacológico y no farmacológico en los pacientes adultos con estreñimiento crónico funcional
en Colombia.
Materiales y métodos: el grupo desarrollador de la presente guía estuvo conformado por un equipo
multidisciplinario con apoyo de la Asociación Colombiana de Gastroenterología, el Grupo Cochrane ITS y
el Instituto de Investigaciones Clínicas de la Universidad Nacional de Colombia. Se desarrollaron preguntas clínicas relevantes y se realizó la búsqueda de guías nacionales e internacionales en bases de datos
especializadas. Las guías existentes fueron evaluadas en términos de calidad y aplicabilidad; ninguna de
ellas cumplió criterios de adaptación, por lo que se decidió desarrollar una guía de novo. El Grupo Cochrane
realizó la búsqueda sistemática de la literatura. Las tablas de evidencia y recomendaciones fueron realizadas
usando la metodología GRADE.
Resultados: se desarrolló una guía de práctica clínica basada en la evidencia para el diagnóstico, clasificación y tratamiento farmacológico y no farmacológico de los pacientes con estreñimiento crónico funcional
en Colombia.
Conclusiones: se establecieron los criterios clínicos y signos de alarma, las pruebas diagnósticas y los
esquemas terapéuticos que se recomiendan en la atención de los pacientes con estreñimiento crónico funcional en Colombia.Guías de práctica clínica basadas en la evidencia57-66Abstract
Objective: Design a clinical practice guideline to orient the diagnosis and establishing the classification and
pharmacological and non-pharmacological treatment in adult patients with chronic functional constipation in
Colombia.
Materials and Methods: This guide was developed by a multidisciplinary team with the support of the
Colombian Association of Gastroenterology, Cochrane STI Group and Clinical Research Institute of the
Universidad Nacional de Colombia. Relevant clinical questions were developed and the search for national
and international guidelines in databases was performed. Existing guidelines were evaluated for quality and
applicability. None of the guidelines met the criteria for adaptation, so the group decided to develop a de novo
guideline. Systematic literature searches were conducted by the Cochrane Group. The tables of evidence and
recommendations were made based on the GRADE methodology.
Results: A clinical practice based on evidence was developed for the diagnosis, classification and pharmacological and non-pharmacological treatment of patients with chronic functional constipation in Colombia.
Conclusions: The clinical criteria and warning signs, diagnostic tests and therapeutic regimens that are
recommended in the care of patients with chronic functional constipation were established in Colombi
Energy Estimation of Cosmic Rays with the Engineering Radio Array of the Pierre Auger Observatory
The Auger Engineering Radio Array (AERA) is part of the Pierre Auger
Observatory and is used to detect the radio emission of cosmic-ray air showers.
These observations are compared to the data of the surface detector stations of
the Observatory, which provide well-calibrated information on the cosmic-ray
energies and arrival directions. The response of the radio stations in the 30
to 80 MHz regime has been thoroughly calibrated to enable the reconstruction of
the incoming electric field. For the latter, the energy deposit per area is
determined from the radio pulses at each observer position and is interpolated
using a two-dimensional function that takes into account signal asymmetries due
to interference between the geomagnetic and charge-excess emission components.
The spatial integral over the signal distribution gives a direct measurement of
the energy transferred from the primary cosmic ray into radio emission in the
AERA frequency range. We measure 15.8 MeV of radiation energy for a 1 EeV air
shower arriving perpendicularly to the geomagnetic field. This radiation energy
-- corrected for geometrical effects -- is used as a cosmic-ray energy
estimator. Performing an absolute energy calibration against the
surface-detector information, we observe that this radio-energy estimator
scales quadratically with the cosmic-ray energy as expected for coherent
emission. We find an energy resolution of the radio reconstruction of 22% for
the data set and 17% for a high-quality subset containing only events with at
least five radio stations with signal.Comment: Replaced with published version. Added journal reference and DO
Measurement of the Radiation Energy in the Radio Signal of Extensive Air Showers as a Universal Estimator of Cosmic-Ray Energy
We measure the energy emitted by extensive air showers in the form of radio
emission in the frequency range from 30 to 80 MHz. Exploiting the accurate
energy scale of the Pierre Auger Observatory, we obtain a radiation energy of
15.8 \pm 0.7 (stat) \pm 6.7 (sys) MeV for cosmic rays with an energy of 1 EeV
arriving perpendicularly to a geomagnetic field of 0.24 G, scaling
quadratically with the cosmic-ray energy. A comparison with predictions from
state-of-the-art first-principle calculations shows agreement with our
measurement. The radiation energy provides direct access to the calorimetric
energy in the electromagnetic cascade of extensive air showers. Comparison with
our result thus allows the direct calibration of any cosmic-ray radio detector
against the well-established energy scale of the Pierre Auger Observatory.Comment: Replaced with published version. Added journal reference and DOI.
Supplemental material in the ancillary file
Recommended from our members
Seminario por la descentralización y el fortalecimiento municipal en Centroamérica
Tabla de contenido: 1. El estado de la cuestión y perspectivas de la descentralización y del gobierno local en Centroamérica. / por Daniel García Gonzáles – 2. Diez Lecciones Aprendidas del Banco Mundial en Descentralización / por Jonas Frank – 3. Estrategia del BCIE en descentralización y fortalecimiento municipal – 4. EXPO-FERIA RIAD 2005: Descentralización y Prácticas Óptimas Municipales – 5. Estrategias de construcción de un estado descentralizado: el papel de los partidos políticos y congresos / por Programa Valores Democráticos y Gerencia Política – 6. Estrategias de construcción de un estado descentralizado: una visión desde el programa valores democráticos y gerencia política de la organización de los estados americanos / por Eduardo Núñez Vargas – 7. El proceso de descentralización en Guatemala / por Luis Felipe Linares – 8. Elementos de Descentralización Fiscal en Guatemala. Diagnóstico y Recomendaciones / por Juan Alberto González Jacobo y Silvia Abigail Molina Zaldaña – 9. La Descentralización Fiscal en El Salvador – 10. Estado Actual y Tendencias del Proceso de Descentralización en Nicaragua. / por Marlene Álvarez – 11. Pacto nacional por la descentralización y el desarrollo local / por Asociación de Municipios de Honduras – 12. Pacto nacional por la descentralización y el desarrollo local (Presentación) – 13. La descentralización y la reforma del estado en Costa Rica / por Roy Rivera A. – 14. Presentación sobre Estado de la Cuestión y Perspectivas del Proceso de Descentralización y Gobierno Local en Centroamérica. / por Daniel GarcíaUT Librarie
Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy
Journal Article; Research Support, Non-U.S. Gov't;BACKGROUND. Either higher levels of initial DNA damage or lower levels of radiation-induced apoptosis in peripheral blood lymphocytes have been associated to increased risk for develop late radiation-induced toxicity. It has been recently published that these two predictive tests are inversely related. The aim of the present study was to investigate the combined role of both tests in relation to clinical radiation-induced toxicity in a set of breast cancer patients treated with high dose hyperfractionated radical radiotherapy. METHODS. Peripheral blood lymphocytes were taken from 26 consecutive patients with locally advanced breast carcinoma treated with high-dose hyperfractioned radical radiotherapy. Acute and late cutaneous and subcutaneous toxicity was evaluated using the Radiation Therapy Oncology Group morbidity scoring schema. The mean follow-up of survivors (n = 13) was 197.23 months. Radiosensitivity of lymphocytes was quantified as the initial number of DNA double-strand breaks induced per Gy and per DNA unit (200 Mbp). Radiation-induced apoptosis (RIA) at 1, 2 and 8 Gy was measured by flow cytometry using annexin V/propidium iodide.
RESULTS. Mean DSB/Gy/DNA unit obtained was 1.70 ± 0.83 (range 0.63-4.08; median, 1.46). Radiation-induced apoptosis increased with radiation dose (median 12.36, 17.79 and 24.83 for 1, 2, and 8 Gy respectively). We observed that those "expected resistant patients" (DSB values lower than 1.78 DSB/Gy per 200 Mbp and RIA values over 9.58, 14.40 or 24.83 for 1, 2 and 8 Gy respectively) were at low risk of suffer severe subcutaneous late toxicity (HR 0.223, 95%CI 0.073-0.678, P = 0.008; HR 0.206, 95%CI 0.063-0.677, P = 0.009; HR 0.239, 95%CI 0.062-0.929, P = 0.039, for RIA at 1, 2 and 8 Gy respectively) in multivariate analysis. CONCLUSIONS. A radiation-resistant profile is proposed, where those patients who presented lower levels of initial DNA damage and higher levels of radiation induced apoptosis were at low risk of suffer severe subcutaneous late toxicity after clinical treatment at high radiation doses in our series. However, due to the small sample size, other prospective studies with higher number of patients are needed to validate these results.This work was subsidized by a grant from the Ministerio de Educación y Ciencia (CICYT: SAF 2004-00889) and Fundación del Instituto Canario de Investigación del Cáncer (FICIC).Yes2011-0
Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 : a multicentre, randomised, double-blind, non-inferiority phase IIb trial
A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study dose-escalation trial. Here, we report the interim results of the Phase IIb HH-2, where the immunogenicity and safety of a heterologous booster with PHH-1V is assessed versus a homologous booster with BNT162b2 at 14, 28 and 98 days after vaccine administration. The HH-2 study is an ongoing multicentre, randomised, active-controlled, double-blind, non-inferiority Phase IIb trial, where participants 18 years or older who had received two doses of BNT162b2 were randomly assigned in a 2:1 ratio to receive a booster dose of vaccine-either heterologous (PHH-1V group) or homologous (BNT162b2 group)-in 10 centres in Spain. Eligible subjects were allocated to treatment stratified by age group (18-64 versus ≥65 years) with approximately 10% of the sample enrolled in the older age group. The primary endpoints were humoral immunogenicity measured by changes in levels of neutralizing antibodies (PBNA) against the ancestral Wuhan-Hu-1 strain after the PHH-1V or the BNT162b2 boost, and the safety and tolerability of PHH-1V as a boost. The secondary endpoints were to compare changes in levels of neutralizing antibodies against different variants of SARS-CoV-2 and the T-cell responses towards the SARS-CoV-2 spike glycoprotein peptides. The exploratory endpoint was to assess the number of subjects with SARS-CoV-2 infections ≥14 days after PHH-1V booster. This study is ongoing and is registered with , . From 15 November 2021, 782 adults were randomly assigned to PHH-1V (n = 522) or BNT162b2 (n = 260) boost vaccine groups. The geometric mean titre (GMT) ratio of neutralizing antibodies on days 14, 28 and 98, shown as BNT162b2 active control versus PHH-1V, was, respectively, 1.68 (p < 0.0001), 1.31 (p = 0.0007) and 0.86 (p = 0.40) for the ancestral Wuhan-Hu-1 strain; 0.62 (p < 0.0001), 0.65 (p < 0.0001) and 0.56 (p = 0.003) for the Beta variant; 1.01 (p = 0.92), 0.88 (p = 0.11) and 0.52 (p = 0.0003) for the Delta variant; and 0.59 (p ≤ 0.0001), 0.66 (p < 0.0001) and 0.57 (p = 0.0028) for the Omicron BA.1 variant. Additionally, PHH-1V as a booster dose induced a significant increase of CD4 + and CD8 + T-cells expressing IFN-γ on day 14. There were 458 participants who experienced at least one adverse event (89.3%) in the PHH-1V and 238 (94.4%) in the BNT162b2 group. The most frequent adverse events were injection site pain (79.7% and 89.3%), fatigue (27.5% and 42.1%) and headache (31.2 and 40.1%) for the PHH-1V and the BNT162b2 groups, respectively. A total of 52 COVID-19 cases occurred from day 14 post-vaccination (10.14%) for the PHH-1V group and 30 (11.90%) for the BNT162b2 group (p = 0.45), and none of the subjects developed severe COVID-19. Our interim results from the Phase IIb HH-2 trial show that PHH-1V as a heterologous booster vaccine, when compared to BNT162b2, although it does not reach a non-inferior neutralizing antibody response against the Wuhan-Hu-1 strain at days 14 and 28 after vaccination, it does so at day 98. PHH-1V as a heterologous booster elicits a superior neutralizing antibody response against the previous circulating Beta and the currently circulating Omicron BA.1 SARS-CoV-2 variants in all time points assessed, and for the Delta variant on day 98 as well. Moreover, the PHH-1V boost also induces a strong and balanced T-cell response. Concerning the safety profile, subjects in the PHH-1V group report significantly fewer adverse events than those in the BNT162b2 group, most of mild intensity, and both vaccine groups present comparable COVID-19 breakthrough cases, none of them severe. HIPRA SCIENTIFIC, S.L.U
- …